Epidemiology of infectious encephalitis causes in 2016;Épidémiologie des causes d'encéphalites infectieuses en 2016

Medecine et Maladies Infectieuses

Volumn 47, Issue 3, 2017, Pages 221-235

  Boucher, A ^a   Herrmann, J L ^b   Morand, P ^c   Buzele R ^d   Crabol, Y ^e   Stahl, J P ^c   Mailles, A ^f  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CHU de Garches   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d centre hospitalier de Saint Brieuc   (France)

^e Centre hospitalier Bretagne Atlantique   (France)

^f SANTÉ PUBLIQUE FRANCE   (France)

Author keywords

Emerging infections; Encephalitis; Enterovirus; Epidemiology; HSV; VZV

Indexed keywords

ADULT; ANIMAL; BACTERIAL INFECTION; CHILD; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FRANCE; GLOBAL HEALTH; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTIOUS ENCEPHALITIS; PARASITOSIS; TRANSMISSION; VACCINATION; VIRUS INFECTION; ZOONOSIS;

ADULT; ANIMALS; BACTERIAL INFECTIONS; CHILD; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FRANCE; GLOBAL HEALTH; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFECTIOUS ENCEPHALITIS; PARASITIC DISEASES; VACCINATION; VIRUS DISEASES; ZOONOSES;

EID: 85019133100     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2017.02.003     Document Type: Review

References (76)

1. [1] Granerod, J., Tam, C.C., Crowcroft, N.S., Davies, N.W.S., Borchert, M., Thomas, S.L., Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology 75:10 (2010), 924–932.
2. [2] Glaser, C.A., Gilliam, S., Schnurr, D., Forghani, B., Honarmand, S., Khetsuriani, N., et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998–2000. Clin Infect Dis 36:6 (2003), 731–742.
3. [3] Glaser, C.A., Honarmand, S., Anderson, L.J., Schnurr, D.P., Forghani, B., Cossen, C.K., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 43:12 (2006), 1565–1577.
4. [4] Granerod, J., Ambrose, H.E., Davies, N.W., Clewley, J.P., Walsh, A.L., Morgan, D., et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:12 (2010), 835–844.
5. [5] Mailles, A., Stahl, J.-P., Steering Committee and Investigators Group, Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 49:12 (2009), 1838–1847.
6. [6] de Ory, F., Avellón, A., Echevarría, J.E., Sánchez-Seco, M.P., Trallero, G., Cabrerizo, M., et al. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol 85:3 (2013), 554–562.
7. [7] Koskiniemi, M., Rantalaiho, T., Piiparinen, H., von Bonsdorff, C.H., Färkkilä, M., Järvinen, A., et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol 7:5 (2001), 400–408.
8. [8] Kupila, L., Vuorinen, T., Vainionpää, R., Hukkanen, V., Marttila, R.J., Kotilainen, P., Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 66:1 (2006), 75–80.
9. [9] Srey, V.H., Sadones, H., Ong, S., Mam, M., Yim, C., Sor, S., et al. Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999–2000. Am J Trop Med Hyg 66:2 (2002), 200–207.
10. [10] Lee, T.-C., Tsai, C.-P., Yuan, C.-L., Wei, C.-Y., Tsao, W.-L., Lee, R.-J., et al. Encephalitis in Taiwan: a prospective hospital-based study. Jpn J Infect Dis 56:5–6 (2003), 193–199.
11. [11] Joshi, R., Mishra, P.K., Joshi, D., Santhosh, S.R., Parida, M.M., Desikan, P., et al. Clinical presentation, etiology, and survival in adult acute encephalitis syndrome in rural Central India. Clin Neurol Neurosurg 115:9 (2013), 1753–1761.
12. [12] Olsen, S.J., Campbell, A.P., Supawat, K., Liamsuwan, S., Chotpitayasunondh, T., Laptikulthum, S., et al. Infectious causes of encephalitis and meningoencephalitis in Thailand, 2003–2005. Emerg Infect Dis 21:2 (2015), 280–289.
13. [13] Khetsuriani, N., Holman, R.C., Anderson, L.J., Burden of encephalitis-associated hospitalizations in the United States, 1988–1997. Clin Infect Dis 35:2 (2002), 175–182.
14. [14] Vora, N.M., Holman, R.C., Mehal, J.M., Steiner, C.A., Blanton, J., Sejvar, J., Burden of encephalitis-associated hospitalizations in the United States, 1998–2010. Neurology 82:5 (2014), 443–451.
15. [15] Kulkarni, M.A., Lecocq, A.C., Artsob, H., Drebot, M.A., Ogden, N.H., Epidemiology and aetiology of encephalitis in Canada, 1994–2008: a case for undiagnosed arboviral agents?. Epidemiol Infect 141:11 (2013), 2243–2255.
16. [16] Davison, K.L., Crowcroft, N.S., Ramsay, M.E., Brown, D.W.G., Andrews, N.J., Viral encephalitis in England, 1989–1998: what did we miss?. Emerg Infect Dis 9:2 (2003), 234–240.
17. [17] Mailles, A., Vaillant, V., Stahl, J.-P., [Infectious encephalitis in France from 2000 to 2002: the hospital database is a valuable but limited source of information for epidemiological studies]. Med Mal Infect 37:2 (2007), 95–102.
18. [18] Huppatz, C., Durrheim, D.N., Levi, C., Dalton, C., Williams, D., Clements, M.S., et al. Etiology of encephalitis in Australia, 1990–2007. Emerg Infect Dis 15:9 (2009), 1359–1365.
19. [19] Barbadoro, P., Marigliano, A., Ricciardi, A., D'Errico, M.M., Prospero, E., Trend of hospital utilization for encephalitis. Epidemiol Infect 140:4 (2012), 753–764.
20. [20] Trevejo, R.T., Acute encephalitis hospitalizations, California, 1990–1999: unrecognized arboviral encephalitis?. Emerg Infect Dis 10:8 (2004), 1442–1449.
21. [21] Mehal, J.M., Holman, R.C., Vora, N.M., Blanton, J., Gordon, P.H., Cheek, J.E., Encephalitis-associated hospitalizations among American Indians and Alaska Natives. Am J Trop Med Hyg 90:4 (2014), 755–759.
22. [22] Kelly, T.A., O'Lorcain, P., Moran, J., Garvey, P., McKeown, P., Connell, J., et al. Underreporting of viral encephalitis and viral meningitis, Ireland, 2005–2008. Emerg Infect Dis 19:9 (2013), 1428–1436.
23. [23] Quist-Paulsen, E., Kran, A.-M.B., Dunlop, O., Wilson, J., Ormaasen, V., Infectious encephalitis: a description of a Norwegian cohort. Scand J Infect Dis 45:3 (2013), 179–185.
24. [24] Rantalaiho, T., Färkkilä, M., Vaheri, A., Koskiniemi, M., Acute encephalitis from 1967 to 1991. J Neurol Sci 184:2 (2001), 169–177.
25. [25] Child, N., Croxson, M.C., Rahnama, F., Anderson, N.E., A retrospective review of acute encephalitis in adults in Auckland over a five-year period (2005–2009). J Clin Neurosci 19:11 (2012), 1483–1485.
26. [26] Frantzidou, F., Kamaria, F., Dumaidi, K., Skoura, L., Antoniadis, A., Papa, A., Aseptic meningitis and encephalitis because of herpesviruses and enteroviruses in an immunocompetent adult population. Eur J Neurol 15:9 (2008), 995–997.
27. [27] Sghaier, W., Bahri, O., Kedous, E., Fazaa, O., Rezig, D., Touzi, H., et al. [Retrospective study of viral causes of central nervous system infections in Tunisia (2003–2009)]. Med Sante Trop 22:4 (2012), 373–378.
28. [28] Buxbaum, S., Geers, M., Gross, G., Schöfer, H., Rabenau, H.F., Doerr, H.W., Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?. Med Microbiol Immunol (Berl) 192:3 (2003), 177–181.
29. [29] Hjalmarsson, A., Blomqvist, P., Sköldenberg, B., Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis 45:7 (2007), 875–880.
30. [30] Armangue, T., Leypoldt, F., Málaga, I., Raspall-Chaure, M., Marti, I., Nichter, C., et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:2 (2014), 317–323.
31. [31] Honnorat, E., De Broucker, T., Mailles, A., Stahl, J.P., le comité de pilotage et groupe des investigateurs, Encephalitis due to Mycobacterium tuberculosis in France. Med Mal Infect 43:6 (2013), 230–238.
32. [32] Maertens de Noordhout, C., Devleesschauwer, B., Angulo, F.J., Verbeke, G., Haagsma, J., Kirk, M., et al. The global burden of listeriosis: a systematic review and meta-analysis. Lancet Infect Dis 14:11 (2014), 1073–1082.
33. [33] Mailles, A., Lecuit, M., Goulet, V., Leclercq, A., Stahl, J.-P., National Study on Listeriosis Encephalitis Steering Committee, Listeria monocytogenes encephalitis in France. Med Mal Infect 41:11 (2011), 594–601.
34. [34] Stahl, J.-P., Mailles, A., Dacheux, L., Morand, P., Epidemiology of viral encephalitis in 2011. Med Mal Infect 41:9 (2011), 453–464.
35. [35] Süss, J., Tick-borne encephalitis in Europe and beyond – the epidemiological situation as of 2007. Euro Surveill, 13(26), 2008 Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18916 [pii=18916].
36. [36] Olsen, S.J., Supawat, K., Campbell, A.P., Anantapreecha, S., Liamsuwan, S., Tunlayadechanont, S., et al. Japanese encephalitis virus remains an important cause of encephalitis in Thailand. Int J Infect Dis 14:10 (2010), e888–e892.
37. [37] Campbell, G.L., Hills, S.L., Fischer, M., Jacobson, J.A., Hoke, C.H., Hombach, J.M., et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 89:10 (2011), 766–774 [774A–774E].
38. [38] Tarantola, A., Goutard, F., Newton, P., de Lamballerie, X., Lortholary, O., Cappelle, J., et al. Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the Mekong region. PLoS Negl Trop Dis, 8(1), 2014, e2533.
39. [39] Ratnam, I., Leder, K., Black, J., Biggs, B.-A., Matchett, E., Padiglione, A., et al. Low risk of Japanese encephalitis in short-term Australian travelers to Asia. J Travel Med 20:3 (2013), 206–208.
40. [40] Hills, S.L., Griggs, A.C., Fischer, M., Japanese encephalitis in travelers from non-endemic countries, 1973–2008. Am J Trop Med Hyg 82:5 (2010), 930–936.
41. [41] Lindsey, N.P., Staples, J.E., Lehman, J.A., Fischer, M., Centers for Disease Control and Prevention (CDC), Surveillance for human West Nile virus disease – United States, 1999–2008. MMWR Morb Mortal Wkly Rep 59:2 (2010), 1–17.
42. [42] Sambri, V., Capobianchi, M., Charrel, R., Fyodorova, M., Gaibani, P., Gould, E., et al. West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect 19:8 (2013), 699–704.
43. [43] Paterson, B.J., Mackenzie, J.S., Durrheim, D.N., Smith, D., A review of the epidemiology and surveillance of viral zoonotic encephalitis and the impact on human health in Australia. New South Wales Public Health Bull 22:5–6 (2011), 99–104.
44. [44] Tyler, K.L., Emerging viral infections of the central nervous system: part 2. Arch Neurol 66:9 (2009), 1065–1074.
45. [45] Chen, S.-C., Chang, H.-L., Yan, T.-R., Cheng, Y.-T., Chen, K.-T., An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg 77:1 (2007), 188–191.
46. [46] Reimann, C.A., Hayes, E.B., DiGuiseppi, C., Hoffman, R., Lehman, J.A., Lindsey, N.P., et al. Epidemiology of neuroinvasive arboviral disease in the United States, 1990–2007. Am J Trop Med Hyg 79:6 (2008), 974–979.
47. [47] Hinten, S.R., Beckett, G.A., Gensheimer, K.F., Pritchard, E., Courtney, T.M., Sears, S.D., et al. Increased recognition of Powassan encephalitis in the United States, 1999–2005. Vector Borne Zoonotic Dis 8:6 (2008), 733–740.
48. [48] Chua, K.B., Bellini, W.J., Rota, P.A., Harcourt, B.H., Tamin, A., Lam, S.K., et al. Nipah virus: a recently emergent deadly paramyxovirus. Science 288:5470 (2000), 1432–1435.
49. [49] Luby, S.P., Hossain, M.J., Gurley, E.S., Ahmed, B.N., Banu, S., Khan, S.U., et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001–2007. Emerg Infect Dis 15:8 (2009), 1229–1235.
50. [50] Hoffmann, B., Tappe, D., Höper, D., Herden, C., Boldt, A., Mawrin, C., et al. A variegated squirrel bornavirus associated with fatal human encephalitis. N Engl J Med 373:2 (2015), 154–162.
51. [51] Goenka, A., Michael, B.D., Ledger, E., Hart, I.J., Absoud, M., Chow, G., et al. Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study. Clin Infect Dis 58:6 (2014), 775–784.
52. [52] Selvey, L.A., Dailey, L., Lindsay, M., Armstrong, P., Tobin, S., Koehler, A.P., et al. The changing epidemiology of Murray Valley encephalitis in Australia: the 2011 outbreak and a review of the literature. PLoS Negl Trop Dis, 8(1), 2014, e2656.
53. [53] Huff, J.L., Barry, P.A., B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease. Emerg Infect Dis 9:2 (2003), 246–250.
54. [54] Go, Y.Y., Balasuriya, U.B.R., Lee, C.-K., Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses. Clin Exp Vaccine Res 3:1 (2014), 58–77.
55. [55] Tandale, B.V., Sathe, P.S., Arankalle, V.A., Wadia, R.S., Kulkarni, R., Shah, S.V., et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol 46:2 (2009), 145–149.
56. [56] Soares, C.N., Cabral-Castro, M.J., Peralta, J.M., de Freitas, M.R.G., Zalis, M., Puccioni-Sohler, M., Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. J Neurol Sci 303:1–2 (2011), 75–79.
57. [57] Yoder, J.S., Eddy, B.A., Visvesvara, G.S., Capewell, L., Beach, M.J., The epidemiology of primary amoebic meningoencephalitis in the USA, 1962–2008. Epidemiol Infect 138:7 (2010), 968–975.
58. [58] Siddiqui, R., Khan, N.A., Balamuthia amoebic encephalitis: an emerging disease with fatal consequences. Microb Pathog 44:2 (2008), 89–97.
59. [59] Siddiqui, R., Khan, N.A., Biology and pathogenesis of Acanthamoeba. Parasit Vectors, 5, 2012, 6.
60. [60] Gavin, P.J., Kazacos, K.R., Shulman, S.T., Baylisascariasis. Clin Microbiol Rev 18:4 (2005), 703–718.
61. [61] Muta, T., Fukuda, T., Harada, M., Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant 43:7 (2009), 583–585.
62. [62] Ogata, M., Satou, T., Kadota, J., Saito, N., Yoshida, T., Okumura, H., et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 57:5 (2013), 671–681.
63. [63] Arribas, J.R., Storch, G.A., Clifford, D.B., Tselis, A.C., Cytomegalovirus encephalitis. Ann Intern Med 125:7 (1996), 577–587.
64. [64] Ando, T., Mitani, N., Yamashita, K., Takahashi, T., Ohama, E., Miyata, H., et al. Cytomegalovirus ventriculoencephalitis in a reduced-intensity conditioning cord blood transplant recipient. Transpl Infect Dis 12:5 (2010), 441–445.
65. [65] Arslan, F., Tabak, F., Avşar, E., Midilli, K., Mert, A., Ozaras, R., et al. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient. J Neurovirol 16:2 (2010), 174–178.
66. [66] Colombo, A.A., Giorgiani, G., Rognoni, V., Villani, P., Furione, M., Bonora, M.R., et al. Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients. BMC Infect Dis, 12, 2012, 238.
67. [67] Julin, J.E., van Burik, J.H., Krivit, W., Webb, C., Holman, C.J., Clark, H.B., et al. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transpl Infect Dis 4:4 (2002), 201–206.
68. [68] Reddy, S.M., Winston, D.J., Territo, M.C., Schiller, G.J., CMV central nervous system disease in stem cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency. Bone Marrow Transplant 45:6 (2010), 979–984.
69. [69] Sarva, H., Graber, J., Remanan, R., Rosenblum, M., Omuro, A., CMV encephalitis in BMT recipients. Bone Marrow Transplant 47:2 (2012), 318–320.
70. [70] Devetag, F.C., Boscariolo, L., Cytomegalovirus meningoencephalitis with paroxysmal course in immunocompetent adults: a new nosographical entity. Clinical, diagnostic and therapeutic correlations, and pathogenetic hypothesis. Eur Neurol 44:4 (2000), 242–247.
71. [71] Ferriby, D., Defebvre, L., Soto-Ares, G., Destee, A., [Cytomegalovirus rhombencephalomyelitis in an immunocompetent subject]. Rev Neurol (Paris) 157:2 (2001), 222–224.
72. [72] Heininger, A., Jahn, G., Engel, C., Notheisen, T., Unertl, K., Hamprecht, K., Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 29:3 (2001), 541–547.
73. [73] Aksamit, A.J., Progressive multifocal leukoencephalopathy. Contin Minneap Minn 18:6 Infectious Disease (2012), 1374–1391.
74. [74] Shitrit, D., Lev, N., Bar-Gil-Shitrit, A., Kramer, M.R., Progressive multifocal leukoencephalopathy in transplant recipients. Transpl Int 17:11 (2005), 658–665.
75. [75] Dromer, F., Mathoulin-Pélissier, S., Launay, O., Lortholary, O., French Cryptococcosis Study Group, Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med, 4(2), 2007, e21.
76. [76] Newsome, J., Nguyen, D., Cryptococcal meningitis caused by Cryptococcus neoformans in an immunocompetent soldier. Mil Med 179:9 (2014), e1059–e1061.